Myocarditis clinical trials
The registry lists 174 studies for Myocarditis across more than 10 countries. 75 are recruiting or about to start. 113 of them are mainly about Myocarditis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.
Get an email when these change. Save the Myocarditis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Assistance Publique - Hôpitaux de Paris (13) · Mayo Clinic (6) · Assiut University (5) · Groupe Hospitalier Pitie-Salpetriere (5) · Medical University of Warsaw (4) · Scientific Institute San Raffaele (4) · University of Edinburgh (3) · Kansas City Heart Rhythm Research Foundation (3)
What is being tested here
Drugs under test in Myocarditis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Drug classes tested here Corticosteroids 1 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Apr 2027Non-Steroidal Anti-Inflammatory Drugs in Acute Myocarditis · Phase 3 · Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
- Nov 2026TIRANA-ACS: A Prospective Registry Study for the Targeted Investigation of Residual Inflammation After Non-ST/ ST Elevation Acute Coronary Syndrome · University Hospital Centre Mother Teresa
- Dec 2026Genomics and COVID-19 Vaccine Adverse Events · University of British Columbia
- Dec 2026Quantitative Cardiac Parametric Mapping · Medical University of South Carolina
- Dec 2026The Application of T1 Mapping in Real-World · Chinese Academy of Medical Sciences, Fuwai Hospital
- Dec 2026A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease · McGill University Health Centre/Research Institute of the McGill University Health Centre
- Dec 2026COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry · Ottawa Heart Institute Research Corporation
- Dec 2026Image-Based Prediction of Ventricular Tachycardias in Post-Myocarditis Patients: an International Multicenter Case-control Study · Centro Medico Teknon
- Mar 2027Rilonacept in Subjects With Cardiac Sarcoidosis · Mayo Clinic
- Mar 2027Mayo AVC Registry and Biobank · Mayo Clinic
Who these studies take
Of the 53 Myocarditis studies recruiting now, 31 (58%) set no upper age limit and 6 (11%) stop at 75 or younger. 15 (28%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 14 (26%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 12 (23%) | 12 (23%) |
| 18 | 50 (94%) | 50 (94%) |
| 30 | 51 (96%) | 51 (96%) |
| 40 | 51 (96%) | 51 (96%) |
| 50 | 51 (96%) | 51 (96%) |
| 65 | 51 (96%) | 51 (96%) |
| 75 | 48 (91%) | 48 (91%) |
| 85 | 39 (74%) | 39 (74%) |
Across all 174 studies, recruiting or not: 18% stop at 75 or younger and 14% at 65; 30% take children; 0% are for women only and 1% for men only; 20% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Myocarditis studies take
Of 71 observational studies under Myocarditis, half reached primary completion within 69 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Observational | 69 mo20–251 · 71 studies | — | 69 mo20–251 · 70 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 11, 2026.
Started recruiting1
Studies
Recruiting first, then most recently updated. Showing 50 of 174. Browse all 174 → or search them.
- The Application of T1 Mapping in Real-WorldRecruitingNCT073546461 country
- Baduanjin Rehabilitation for Functional Restoration in ICI-Associated MyocarditisRecruitingNCT07280429Not applicable1 country
- Monitoring and Rehabilitation for ICIACI Rehabilitation:A Cohort StudyNot yet recruitingNCT07278817
- A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac DiseaseRecruitingNCT044646551 country
- MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance StudyRecruitingNCT061031231 country
- Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory SupportRecruitingNCT07482865Not applicable1 country
- JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint InhibitorsRecruitingNCT042947711 country
- Multimodal Physiologic State Intelligence StudyEnrolling by invitationNCT078141181 country
- Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis TransitionRecruitingNCT064095851 country
- Rilonacept in Subjects With Cardiac SarcoidosisRecruitingNCT06660732Phase 21 country
- Abatacept in Immune Checkpoint Inhibitor MyocarditisRecruitingNCT05335928Phase 32 countries
- MCE Molecular Imaging for MyocarditisNot yet recruitingNCT07538544Early Phase 11 country
- Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular ResearchNot yet recruitingNCT07737470
- Multimodal mAgnetic Resonance imaGIng in Cardiovascular DiseaseRecruitingNCT076178441 country
- One-year Prognostic Impact of Microcirculation Assessed by NH IMR Angio in Patients Hospitalized for Acute MyocarditisNot yet recruitingNCT07676201
- ATROPOS: Survival Analysis of ICI-associated MyocarditisRecruitingNCT076335871 country
- EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular DiseasesRecruitingNCT070773041 country
- Genomics and COVID-19 Vaccine Adverse EventsRecruitingNCT052127921 country
- Mayo AVC Registry and BiobankRecruitingNCT030492542 countries
- CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With ColchicineRecruitingNCT06158698Phase 31 country
- Tissue and Metabolic Characterization of Arrhythmogenic Cardiomyopathies by Hybrid PET-MRI Imaging, Impact of the Observed Profiles on the Phenotype and on the Evolution of CardiomyopathyRecruitingNCT054507831 country
- The Heart Hive - Cardiomyopathy StudyRecruitingNCT046122961 country
- Colchicine Versus Placebo in Acute Myocarditis PatientsRecruitingNCT05855746Phase 31 country
- Non-Steroidal Anti-Inflammatory Drugs in Acute MyocarditisRecruitingNCT06686862Phase 31 country
- Cardiac Imaging in Systemic Disorders: the ORACLES RegistryNot yet recruitingNCT07134166
- French Registry of CMR Late Gadolinium Enhancement in MyocarditisNot yet recruitingNCT07394543
- ANAKINRA IN THE TREATMENT OF PEDIATRIC ACUTE MYOCARDITISNot yet recruitingNCT07371689Phase 31 country
- COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence RegistryRecruitingNCT050460021 country
- Multimodal Analysis of Endomyocardial BiopsiesRecruitingNCT073596901 country
- Cardiac MRI in Myocarditis and Inflammatory CardiomyopathyEnrolling by invitationNCT07325968
- IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatIONRecruitingNCT044441281 country
- Multicenter Study on Cardiovascular and Metabolic Complications in Patients With Biochemically Silent Pheochromocytomas and ParagangliomasEnrolling by invitationNCT073160751 country
- Assessment of the Predictive Value of Anti-beta1AR and Anti-L-CaC Antibodies in the Evolution to Dilated Cardiomyopathy in Patients With Acute Viral MyocarditisRecruitingNCT067420081 country
- Genetic Determinants of Myocarditis Induced by Immune-checkpoint InhibitorsRecruitingNCT067346891 country
- Quantitative Cardiac Parametric MappingRecruitingNCT02855554Not applicable1 country
- TIRANA-ACS: A Prospective Registry Study for the Targeted Investigation of Residual Inflammation After Non-ST/ ST Elevation Acute Coronary SyndromeRecruitingNCT070267081 country
- Outcome of Clinical Phenotypes of Pediatric Myocarditis at Assiut University Children HospitalNot yet recruitingNCT07175948
- Myocarditis Causing Premature Ventricular Contractions:Insights From the MAVERIC RegistryNot yet recruitingNCT051587511 country
- The ORCHESTRATE-Myocarditis RegistryNot yet recruitingNCT051393291 country
- Role of Novel ILR in the Management of PVCsRecruitingNCT060605481 country
- MYTHS - MYocarditis THerapy With SteroidsRecruitingNCT05150704Phase 39 countries
- Efficacy of a Myocardial Panel in the Management and Treatment of Pediatric MyocarditisRecruitingNCT07086144Not applicable1 country
- Sepsis and MyocarditisRecruitingNCT070796051 country
- Acute Myocarditis Registry With Prognostic, Histologic, Immunologic, Biological, Imaging and Clinical AssessmentRecruitingNCT048441511 country
- Prevalence of Myocarditis in Patients Suspected Myocardial Infarction With Non-Obstructive Coronary ArteriesNot yet recruitingNCT06966531
- Validating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis PatientsRecruitingNCT035865181 country
- MYTHS-MR Trial (MYocarditis THerapy With Steroids in Patients With Mildly Reduced Ejection Fraction)RecruitingNCT05974462Phase 34 countries
- the Role of cArdiac Inflammation, endoThelial Dysfunction, and FIbrosis in fabrY DiseaseRecruitingNCT067764191 country
- Creation of a National Multicenter Platform for the Study of Inflammatory Myocardial Disease: Pre-MYO CohortRecruitingNCT068987621 country
- Pulse Corticosteroids Or/and Immunoglobulins to Treat Fulminant MyocarditisNot yet recruitingNCT06896253Phase 2